Delivery Order SPE2DB22D2206-SPE2DB26FDR67
Award Date 10/20/25
Potential Completion Date 11/10/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials, valued at $10,916.78, with a completion date of July 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products, with an order quantity of 20,000 units in 10ML vials. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This delivery order, valued at $16,375.17, was awarded on August 21, 2025, to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 mg in 10 mL unit dosages totaling 20,000 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain. The award was made on a competitive basis without any set-aside designation. AmerisourceBergen's place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10 mL vials. This is an unset-aside, competitively awarded contract with a completion date of June 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,005.84 firm fixed-price delivery order is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has an ultimate completion date of January 20, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase-oysk) 1,200-600 mg in 15 ml vials, with a quantity of 30,000 units and a ceiling value of $8,225.30. This is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, issued under a non-set-aside, competitively awarded procurement process. The work will be performed at AmerisourceBergen's...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,009.64, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has an ultimate completion date of January 17, 2025 and was awarded on December 26, 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 mL unit doses totaling 20,000 units. The contract, awarded on September 16, 2025, with an ultimate completion date of October 7, 2025, utilizes firm fixed pricing under a non-competitive delivery order structure. This order will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,225.29 delivery order to AmerisourceBergen Drug Corp for PHESGO (pertuzumab, trastuzumab, and hyaluronidase-oysk), a specialty pharmaceutical product used in cancer treatment. The delivery order, issued on August 6, 2025, calls for 30,000 units of the 1,200-600 mg/15mL formulation with an ultimate completion date of August 27, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded....